2026-01-02 - Analysis Report
Okay, let's break down the analysis of Tempus AI Inc. (TEM) based on the provided data.

**1) Return Rate Comparison:**

*   **TEM Cumulative Return:** 5.46%
*   **S&P 500 (VOO) Cumulative Return:** 30.53%
*   **Divergence:** -25.1 (Relative Divergence: 13.5)

**Analysis:**

*   TEM has significantly underperformed the S&P 500 (VOO) over the analyzed period.
*   The divergence of -25.1 indicates a substantial difference in cumulative return.
*   The Relative Divergence of 13.5 suggests that the current divergence is near the lower end of its historical range.
*   **Company Overview:** Tempus AI Inc. is an AI-powered precision medicine company.

**Alpha, Beta Analysis:**

*   **CAGR (2023-2025):** 69.0%
*   **MDD (2023-2025):** 76.7%
*   **Alpha:** 43.0%
*   **Beta:** 2.8
*   **Cap(B):** 10.5

**Analysis:**

*   The high CAGR of 69% suggests strong growth potential during the 2023-2025 period.
*   The large MDD of 76.7% indicates that the stock is prone to significant drops.
*   A high Alpha of 43.0% indicates that the stock has the potential to outperform its benchmark index by a large margin.
*   A Beta of 2.8 indicates that the stock is 2.8 times more volatile than the market, confirming the risk implied by the high MDD.
*   The given information indicates that TEM is a large-cap stock.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 59.05
*   **Previous Close:** 60.39
*   **Change:** -2.22
*   **5-day SMA:** 61.57
*   **20-day SMA:** 68.35
*   **60-day SMA:** 77.41

**Analysis:**

*   TEM's stock price is currently trending downwards, as it is below all three SMAs.
*   The short-term (5-day SMA) is below the longer-term (20-day, 60-day SMA) moving averages, confirming the downward trend.
*   The change from previous close suggests some fluctuation, but without historical data, its significance is hard to gauge beyond noting the price decrease.

**3) Technical Indicators & Signals:**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 15.83 (Oversold)
*   **PPO:** -1.09
*   **Hybrid Signal:** Buy 100% (Very Safe)
*   **Recent Divergence Change:** -7.3 (Short-term Decline)
*   **Expected Return:** 0.0%

**Analysis:**

*   Despite the MRI indicating high investment recommendation (based on the model's criteria), the RSI of 15.83 suggests the stock is heavily oversold and *could* be due for a rebound (though oversold conditions can persist).
*   A negative PPO indicates a bearish trend.
*   The "Hybrid Signal" suggests a buying opportunity based on the model's algorithm. However, this should be weighed against other indicators, especially the poor historical returns versus the S&P 500.
*   The recent negative divergence change confirms the short-term downward trend.
*   An expected return of 0% suggests that the model predicts no excess return above the market rate if you were to buy the stock today.

**4) Recent News & Significant Events:**

*   **Positive AI Boom Outlook (2026):** A Nasdaq article highlights TEM as a MedTech stock poised to gain from the AI boom in 2026.
*   **Buy/Hold/Sell Debate:** Multiple articles (Yahoo Finance, Zacks) discuss whether TEM is a Buy, Hold, or Sell during its "pivotal transition." This suggests a period of uncertainty or significant change for the company.
*   **Recent Price Drop:** Quiver Quantitative reports an 8% drop in the stock price during the past week.
*   **Strong Performance Claim:** An AOL.com article boasts a 150%+ year-to-date increase, but this is not reflective of the cumulative return provided.
*   **Lowered Price Target:** MarketBeat reports that JPMorgan Chase & Co. lowered its expectations for TEM's stock price.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.14)
*   **Target Price:** $88.92 (Avg), $105 (High), $80 (Low)
*   **Recent Rating Changes:** None specified in the provided data.

**Analysis:**

*   The analyst consensus leans towards a "Buy" rating.
*   The average target price of $88.92 suggests significant upside potential from the current price of $59.05. However, the lowered price target by JPMorgan Chase, suggests that the market is not optimistic regarding TEM's future potential.
*   The wide range between high and low target prices ($80-$105) indicates uncertainty among analysts.

**5) Comprehensive Analysis:**

Overall, the analysis paints a mixed picture of Tempus AI Inc. (TEM).

*   **Negative Signals:** TEM has significantly underperformed the S&P 500. Recent price action is negative. Some analysts have lowered their price targets. The company is in a "pivotal transition," implying uncertainty.
*   **Positive Signals:** The company has a high growth rate. Analyst consensus is "Buy" with a significantly higher target price. The MRI indicates a high investment recommendation. It is positioned to benefit from the AI boom in healthcare.
*   **Risks:** TEM is a volatile stock. Its recent negative price action cannot be ignored. The divergence from the S&P 500 is substantial. The difference between high and low analyst price targets implies a wide range of possibilities.

**Conclusion:**

Investing in TEM appears to be a high-risk, high-reward proposition. The stock's current oversold condition *could* present a buying opportunity for investors with a high-risk tolerance and a long-term investment horizon. However, the underperformance relative to the S&P 500, the recent price decline, and the analyst downgrades suggest caution. Investors should carefully weigh the potential upside against the significant risks before investing in TEM. In addition, be aware that the positive article claiming >150% return in 2026 is not aligned with the provided cumulative return data, so it is not credible. The company needs to successfully navigate its "pivotal transition" to realize its potential.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.